Autolus director granted options and RSUs

Autolus Therapeutics plc director Cynthia M. Butitta received new equity awards.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Autolus Therapeutics plc director Cynthia M. Butitta received new equity awards. She was granted options to buy 47,500 shares of American Depositary Shares at an exercise price of $1.61 per share, expiring on June 29, 2036, vesting in twelve equal monthly installments starting July 29, 2026.

She also received 31,667 restricted share units, each representing one American Depositary Share, vesting in a single installment on June 29, 2027. These awards are compensation-related grants rather than open‑market purchases or sales.

Insider Trade Summary

Grant/Award: 79,167 shares

Grant/Award 2 txns

Insider BUTITTA CYNTHIA M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	31,667	$0.00	$0.00
Grant/Award	Share Option (Right to Buy)	47,500	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 31,667 contracts (Direct); Share Option (Right to Buy) — 47,500 contracts (Direct)

Footnotes (3)

F1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
F2. The RSUs vest in one installment on June 29, 2027.
F3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

Key Figures

Stock options granted: 47,500 shares Option exercise price: $1.61/share Option expiration: June 29, 2036 +3 more

6 metrics

Stock options granted 47,500 shares Share Option (Right to Buy) grant on June 29, 2026

Option exercise price $1.61/share Exercise price for 47,500 options

Option expiration June 29, 2036 Expiration date of granted options

RSUs granted 31,667 units Restricted Share Units grant on June 29, 2026

RSU vesting date June 29, 2027 Single-installment vesting for RSUs

Option vesting start July 29, 2026 Monthly vesting begins, 12 equal installments

Key Terms

Restricted Share Units, Share Option (Right to Buy), American Depositary Shares, restricted stock unit (RSU), +1 more

5 terms

American Depositary Shares financial

"underlying_security_title: "American Depositary Shares""

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

restricted stock unit (RSU) financial

"Each restricted stock unit (RSU) represents a contingent right to receive one share"

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

exercise price financial

"conversion_or_exercise_price: "1.6100""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Autolus Therapeutics (AUTL) director Cynthia Butitta receive in this Form 4?

Cynthia M. Butitta received equity compensation consisting of stock options and restricted share units. She was granted options on 47,500 American Depositary Shares and 31,667 restricted share units, both tied to Autolus Therapeutics plc, with specific vesting schedules over future dates.

How many Autolus Therapeutics (AUTL) options were granted to Cynthia Butitta?

She was granted options on 47,500 American Depositary Shares. These options carry a fixed exercise price of $1.61 per share and expire on June 29, 2036, with vesting occurring in twelve equal monthly installments beginning July 29, 2026.

What are the details of the RSU grant to the Autolus (AUTL) director?

Cynthia Butitta received 31,667 restricted share units, each representing one American Depositary Share of Autolus Therapeutics. According to the filing, these RSUs vest in a single installment on June 29, 2027, making them a time-based equity compensation award.

Are these Autolus (AUTL) transactions open-market buys or sells?

No, the transactions are equity awards, not market trades. The Form 4 classifies them under code A as grants or awards, meaning they are compensation-related acquisitions rather than open-market purchases or sales of Autolus Therapeutics shares.

What does the $1.61 exercise price mean for Autolus (AUTL) option grants?

The $1.61 exercise price is the fixed amount Cynthia Butitta must pay per share to exercise her options. She can acquire American Depositary Shares at this price before the options’ expiration on June 29, 2036, subject to the vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/01/2026 - 04:11 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BUTITTA CYNTHIA M

(Last)

(First)

(Middle)

THE MEDIAWORKS, WHITE CITY

C/O AUTOLUS THERAPEUTICS PLC

(Street)

LONDON

W12 7FP

(City)

(State)

(Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Share Units	⁽¹⁾	06/29/2026		A		31,667		⁽²⁾	⁽²⁾	American Depositary Shares	31,667	$0	31,667	D
Share Option (Right to Buy)	$1.61	06/29/2026		A		47,500		⁽³⁾	06/29/2036	American Depositary Shares	47,500	$0	47,500	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.

2. The RSUs vest in one installment on June 29, 2027.

3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

	/s/ Cynthia Butitta	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR